PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 217 (xsd:integer)
nif:isString
  • Vemurafenib was licensed for the treatment of nonresectable metastatic melanoma by the Food and Drug Administration Agency in the USA in August 2011 and by the European Medicines Agency in Europe in February 2012 [1].
rdf:type